IDH wild type glioblastoma

Clinical trials for IDH wild type glioblastoma explained in plain language.

Never miss a new study

Get alerted when new IDH wild type glioblastoma trials appear

Sign up with your email to follow new studies for IDH wild type glioblastoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug combo targets Hard-to-Treat cancers with MTAP deletion

Disease control Ongoing

This early-stage trial is testing a new oral drug called S095035, alone or combined with another drug (TNG462), in 60 adults with advanced solid tumors that have a specific genetic deletion (MTAP). These cancers have not responded to at least one prior treatment. The study aims t…

Matched conditions: IDH WILD TYPE GLIOBLASTOMA

Phase 1/2 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control

Last updated Aug 27, 2026 00:00 UTC

IDH wild type glioblastoma

Get alerted when new IDH wild type glioblastoma trials appear

New drug combo targets Hard-to-Treat cancers with MTAP deletion